ANI Pharmaceuticals Inc (ANIP) — Capital Reinvestment Ratio
ANI Pharmaceuticals Inc (ANIP) has a Capital Reinvestment Ratio of 0.79x as of December 2025, meaning it reinvests 1% of its operating cash flow ($30.37 Million) in capital expenditures ($23.86 Million). See ANI Pharmaceuticals Inc (ANIP) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ANI Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2025)
This chart tracks ANI Pharmaceuticals Inc's Capital Reinvestment Ratio across 12 annual periods. Check total reinvestment intensity of ANI Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ANI Pharmaceuticals Inc (2007–2025)
Year-by-year Capital Reinvestment Ratio for ANI Pharmaceuticals Inc from 2007 to 2025. For live market cap and broader valuation context, see market value of ANI Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | $185.22 Million | $13.84 Million | ▼ -71.8% |
| 2024 | 0.26x | $64.02 Million | $16.95 Million | ▲ +70.2% |
| 2023 | 0.16x | $118.96 Million | $18.51 Million | ▼ -97.8% |
| 2021 | 7.12x | $3.32 Million | $23.64 Million | ▲ +59.0% |
| 2020 | 4.48x | $15.27 Million | $68.32 Million | ▲ +641.2% |
| 2019 | 0.60x | $45.63 Million | $27.55 Million | ▲ +271.1% |
| 2018 | 0.16x | $67.07 Million | $10.91 Million | ▼ -94.1% |
| 2017 | 2.74x | $39.42 Million | $107.99 Million | ▼ -49.5% |
| 2016 | 5.43x | $27.47 Million | $149.06 Million | ▲ +186.6% |
| 2015 | 1.89x | $17.26 Million | $32.68 Million | ▲ +16.7% |
| 2014 | 1.62x | $22.03 Million | $35.75 Million | ▲ +3980.5% |
| 2007 | 0.04x | $739.99K | $29.43K | — |